Safe Reduction in CD4 Cell Count Monitoring in Stable, Virally Suppressed Patients With HIV Infection or HIV/Hepatitis C Virus Coinfection
Author(s) -
David Nicolás,
Anna EsteveCodina,
Anna Cuadros,
Colin Campbell,
Cristina Tural,
Daniel Podzamczer,
Javier Murillas,
Francisco Homar,
Ferrán Segura,
Lluís Force,
Josep Vilaró,
Àngels Masabeu,
Felipe García,
Jordi Mercadal,
Alexandra Montoliu,
Elena Ferrer,
Melcior Riera,
Carmen Luna,
Juan Ambrosioni,
Gemma Navarro,
Christian Manzardo,
Bonaventura Clotet,
Josep M. Gatell,
Jordi Casabona,
José M. Miró
Publication year - 2016
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/ciw157
Subject(s) - coinfection , medicine , hepatitis c virus , cohort , immunology , population , gastroenterology , human immunodeficiency virus (hiv) , virology , virus , environmental health
It has been suggested that routine CD4 cell count monitoring in human immunodeficiency virus (HIV)-monoinfected patients with suppressed viral loads and CD4 cell counts >300 cell/μL could be reduced to annual. HIV/hepatitis C virus (HCV) coinfection is frequent, but evidence supporting similar reductions in CD4 cell count monitoring is lacking for this population. We determined whether CD4 cell count monitoring could be reduced in monoinfected and coinfected patients by estimating the probability of maintaining CD4 cell counts ≥200 cells/µL during continuous HIV suppression.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom